Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
- 1 October 2007
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 139 (3) , 511-512
- https://doi.org/10.1111/j.1365-2141.2007.06806.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levelsHaematologica, 2007
- Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelBlood, 2007
- Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia veraLeukemia, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyThe Lancet, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Evaluation of diagnostic criteria in polycythemia veraSeminars in Hematology, 2001